ebook Munafa Stock Market Course + Intraday & FNO calls  

       

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast for Editas Medicine Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Editas Medicine EDIT at this time. Stock is falling and might fall more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

My analysis of Editas Medicine is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Editas Medicine stays below 1.9, but if it comes above 1.9, then a intra day buy could be more profitable.
If you take a sell trade below 1.9, then use 1.9 as stoploss and 1.7 as target. However if you take a buy trade in Editas Medicine, then use 1.9 as stoploss and 2.03 as target.

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

RBI moves to push credit delivery, doubles collateral-free loans to MSMEs The central bank has proposed allowing banks to lend to REITs and doubled collateral-free loan limits for MSMEs, signalling a stronger push to widen credit access amid robust loan growth - NEWS as on 2026-02-06 business-standard.com

Flexi-cap equity, credit core bets for 2026: Motilal backs 50% large caps Large caps/hybrids should be considered as portfolio anchors for 2026, complemented by staggered, selective exposure to mid and small caps on the back of improving sentiment - NEWS as on 2026-02-05 business-standard.com

Banks look to get export credit lines ready as US lowers tariff Banks are poised to reopen credit lines for Indian export sectors following the US's reduction of import tariffs to 18%. This move is expected to quickly revive exports of garments, gems, jewelry, leather, and chemicals, leading to increased demand for ban - NEWS as on 2026-02-04 indiatimes.com

Private life insurers see early signs of recovery in credit life business In a post-earnings analyst call, ICICI Prudential Life Insurance's management said the MFI-linked credit life segment has begun to revive during the quarter - NEWS as on 2026-02-04 business-standard.com

Need for inclusive credit strategies for unbanked population: DFS secretary to banks New initiatives aim to boost credit access for the unbanked. The BAANKNET app and Digital Balance Confirmation Platform were launched to streamline property auctions and audits. The PSB Alliance is encouraged to broaden its services. These steps support fi - NEWS as on 2026-02-03 indiatimes.com

Economic Survey calls for tighter credit practices at microfinance institutions The Economic Survey also noted that while private equity and venture capital funding has fuelled the expansion of the microfinance sector, it has also been accompanied by recurring stress, including over-lending and over-indebtedness. - NEWS as on 2026-01-29 indiatimes.com

MFIs need to strengthen credit assessment, curb rising stress The Economic Survey also noted that while private equity and venture capital funding has fuelled the expansion of the microfinance sector, it has also been accompanied by recurring stress, including over-lending and over-indebtedness. - NEWS as on 2026-01-29 indiatimes.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 1.9
  • 12Day Average: 2.03
  • 20Day Average: 2.06
  • 50Day Average: 2.2
  • 100Day Average: 2.71
  • 150Day Average: 2.72
  • 200Day Average: 2.49

EDIT Indicators & signals

Indicator MACD (12,26,9)

1.97, 2.08, -0.09
Indicator MACD is in negative zone

Indicator ADX (14)

0, 36.84, 36.84
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Fri Feb 2026 1.82 1.69 to 1.95 9.64% 1.11 times
05 Thu Feb 2026 1.66 1.66 to 1.95 -14.87% 1.42 times
04 Wed Feb 2026 1.95 1.93 to 2.07 -5.34% 0.87 times
03 Tue Feb 2026 2.06 1.97 to 2.11 2.49% 1.05 times
02 Mon Feb 2026 2.01 1.95 to 2.07 1.01% 0.99 times
30 Fri Jan 2026 1.99 1.92 to 2.07 -3.4% 1 times
29 Thu Jan 2026 2.06 2.01 to 2.11 0% 0.85 times
28 Wed Jan 2026 2.06 2.02 to 2.14 -2.37% 0.79 times
27 Tue Jan 2026 2.11 2.06 to 2.17 2.43% 0.82 times
26 Mon Jan 2026 2.06 2.05 to 2.16 -4.19% 0.88 times
23 Fri Jan 2026 2.15 2.15 to 2.40 -10.04% 1.33 times
22 Thu Jan 2026 2.39 2.11 to 2.43 12.74% 2.14 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top